BlueSky Immunotherapies GmbH
PrivateLast Round
Grant
Nov 1, 2022
Total Funding Raised
$430,000
Company Overview
BlueSky Immunotherapies GmbH operates in Healthcare & Life Sciences and is based in Vienna. Its latest recorded funding round was a Grant round in November 2022.
BlueSky Immunotherapies GmbH is a biotechnology company that develops next-generation immunotherapies using a proprietary interferon-inducing viral vector technology platform for the treatment of cancer and infectious diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BlueSky Immunotherapies GmbH Comparables
Compare BlueSky Immunotherapies GmbH with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Nykode Therapeutics | 77% | |
| PDS Biotechnology Corp | 76% | |
| Hookipa Pharma | 75% |
For institutional investors. Book with your work email.
BlueSky Immunotherapies GmbH Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
BlueSky Immunotherapies GmbH Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| FFG Austrian Research Promotion Agency | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 16, 2026
Monthly visitors increased 166% MoM.
- Apr 2, 2026
Monthly visitors increased 66% MoM.
For institutional investors. Book with your work email.
BlueSky Immunotherapies GmbH Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about BlueSky Immunotherapies GmbH's valuation, stock price, and market status.
Is BlueSky Immunotherapies GmbH a public or private company?
BlueSky Immunotherapies GmbH is a private company.
What is the current stock price of BlueSky Immunotherapies GmbH?
BlueSky Immunotherapies GmbH is a private company, so its shares have no public market price. Caplight tracks BlueSky Immunotherapies GmbH's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is BlueSky Immunotherapies GmbH worth (valuation)?
Valuation information for BlueSky Immunotherapies GmbH is not publicly available.
Can I buy BlueSky Immunotherapies GmbH stock?
BlueSky Immunotherapies GmbH shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was BlueSky Immunotherapies GmbH's last funding round?
BlueSky Immunotherapies GmbH's most recent funding round was Grant on November 1, 2022.
Who are the main investors in BlueSky Immunotherapies GmbH?
Key investors in BlueSky Immunotherapies GmbH include FFG Austrian Research Promotion Agency.
Will BlueSky Immunotherapies GmbH IPO soon?
No public IPO plans have been announced for BlueSky Immunotherapies GmbH.
How can I track BlueSky Immunotherapies GmbH secondary market activity?
Caplight tracks bids, offers, and trades in BlueSky Immunotherapies GmbH's shares on secondary markets.